Recognizing Lean Liver Disease in Clinical Practice Clinicians should consider metabolic liver disease in patients who present with: Normal BMI but central adiposity (increased waist circumference) Mildly elevated liver enzymes without a clear cause Dyslipidemia or insulin resistance features Fatty liver on incidental imaging Routine use of noninvasive tests such as FIB4, ELF score, or transient elastography can help stratify risk and guide hepatology referrals
However, anybody who has a history of food allergy should avoid consuming this formula
What improvements did Novo Nordisk make to GLP-1 therapy
At Meeting Point Health, we often favor IV peptide therapy for its 100% bioavailability
Glutathione can be administered once a month, once a week, or twice a week via subcutaneous injection
This is an evolving field, and what's described here reflects the best available human evidence as of 2025, not a decades-long consensus